Microbial poly(3-hydroxybutyrate) (PHB) has several advantages including its biocompatibility and ability to degrade in vivo and in vitro without toxic substances. This paper investigates the feasibility of electrospun PHB meshes serving as drug delivery systems. The morphology of the electrospun samples was modified by varying the concentration of PHB in solution and the solvent composition. Scanning electron microscopy of the electrospun PHB scaffolds revealed the formation of different morphologies including porous, filamentous/beaded and fiber structures. Levofloxacin was used as the model drug for incorporation into PHB electrospun meshes. The entrapment efficiency was found to be dependent on the viscosity of the PHB solution used for electrospinning and ranged from 14.4-81.8%. The incorporation of levofloxacin in electrospun meshes was confirmed by Fourier-transform infrared spectroscopy and UV-VIS spectroscopy. The effect of the morphology of the electrospun meshes on the levofloxacin release profile was screened in vitro in phosphate-buffered saline solution. Depending upon the morphology, the electrospun meshes released about 14-20% of levofloxacin during the first 24 h. The percentage of drug released after 13 days increased up to 32.4% and was similar for all tested morphologies. The antimicrobial efficiency of all tested samples independent of the morphology, was confirmed by agar diffusion testing.

Department of Food Chemistry and Biotechnology Faculty of Chemistry Brno University of Technology Purkynova 118 612 00 Brno Czech Republic

Department of Physical and Applied Chemistry Faculty of Chemistry Brno University of Technology Purkynova 118 612 00 Brno Czech Republic

Zobrazit více v PubMed

Sudhakar Y., Jayaveera K.N. Novel Drug Delivery Systems and Regulatory Affairs. SCHAND & Company Limited; New Delhi, India: 2014.

Langer R., Peppas N.A. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 2003;49:2990–3006. doi: 10.1002/aic.690491202. DOI

Forbes D.C., Peppas N.A. Oral delivery of small RNA and DNA. J. Control. Release. 2012;162:438–445. doi: 10.1016/j.jconrel.2012.06.037. PubMed DOI

Acar H., Ting J.M., Srivastava S., La Belle J.L., Tirrell M.V. Molecular engineering solutions for therapeutic peptide delivery. Chem. Soc. Rev. 2017;46:6553–6569. doi: 10.1039/C7CS00536A. PubMed DOI

Shi J., Votruba A.R., Farokhzad O.C., Langer R. Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications. Nano Lett. 2010;10:3223–3230. doi: 10.1021/nl102184c. PubMed DOI PMC

Li J., Fan C., Pei H., Shi J., Huang Q. Smart Drug Delivery Nanocarriers with Self-Assembled DNA Nanostructures. Adv. Mater. 2013;25:4386–4396. doi: 10.1002/adma.201300875. PubMed DOI

Liu D., Yang F., Xiong F., Gu N. The smart drug delivery system and its clinical potential. Theranostics. 2016;6:1306–1323. doi: 10.7150/thno.14858. PubMed DOI PMC

Ramasamy T., Ruttala H.B., Gupta B., Poudel B.K., Choi H.-G., Yong C.S., Kim J.O. Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review. J. Control. Release. 2017;258:226–253. doi: 10.1016/j.jconrel.2017.04.043. PubMed DOI

Rezaie H.R., Bakhtiari L., Öchsner A. A Review of Biomaterials and their Applications in Drug Delivery. Springer; Singapore: 2018.

Park K. Controlled drug delivery systems: Past forward and future back. J. Control. Release. 2014;190:3–8. doi: 10.1016/j.jconrel.2014.03.054. PubMed DOI PMC

Rancan F., Papakostas D., Hadam S., Hackbarth S., Delair T., Primard C., Verrier B., Sterry W., Blume-Peytavi U., Vogt A. Investigation of Polylactic Acid (PLA) Nanoparticles as Drug Delivery Systems for Local Dermatotherapy. Pharm. Res. 2009;26:2027–2036. doi: 10.1007/s11095-009-9919-x. PubMed DOI

Pellis A., Silvestrini L., Scaini D., Coburn J.M., Gardossi L., Kaplan D.L., Herrero Acero E., Guebitz G.M. Enzyme-catalyzed functionalization of poly(L-lactic acid) for drug delivery applications. Pt AProcess. Biochem. 2017;59:77–83. doi: 10.1016/j.procbio.2016.10.014. DOI

Fukuzaki H., Yoshida M., Asano M., Kumakura M., Mashimo T., Yuasa H., Imai K., Yamanaka H. In vivo characteristics of high molecular weight copoly(L-lactide/glycolide) with S-type degradation pattern for application in drug delivery systems. Biomaterials. 1991;12:433–437. doi: 10.1016/0142-9612(91)90014-2. PubMed DOI

Xu P., Gullotti E., Tong L., Highley C.B., Errabelli D.R., Hasan T., Cheng J.-X., Kohane D.S., Yeo Y. Intracellular Drug Delivery by Poly(lactic-co-glycolic acid) Nanoparticles, Revisited. Mol. Pharm. 2009;6:190–201. doi: 10.1021/mp800137z. PubMed DOI PMC

Xiao Y., Yuan M., Zhang J., Yan J., Lang M. Functional Poly(ε-caprolactone) Based Materials: Preparation, Self-assembly and Application in Drug Delivery. Curr. Top. Med. Chem. 2014;14:781–818. doi: 10.2174/1568026614666140118222820. PubMed DOI

Michalak M., Kurcok P., Hakkarainen M. Polyhydroxyalkanoate-based drug delivery systems. Polym. Int. 2017;66:617–622. doi: 10.1002/pi.5282. DOI

Shrivastav A., Kim H.-Y., Kim Y.-R. Advances in the applications of polyhydroxyalkanoate nanoparticles for novel drug delivery system. BioMed Res. Int. 2013;2013:581684. doi: 10.1155/2013/581684. PubMed DOI PMC

Merli D., Profumo A., Quadrelli P., Arciola C.R., Visai L. Drug Delivery Systems for Chemotherapeutics through Selected Polysaccharidic Vehicles. Curr. Org. Chem. 2018;22:1157–1192. doi: 10.2174/1385272822666180122161444. DOI

Salehi Dashtebayaz M.S., Nourbakhsh M.S. Interpenetrating networks hydrogels based on hyaluronic acid for drug delivery and tissue engineering. Int. J. Polym. Mater. Polym. Biomater. 2019;68:442–451. doi: 10.1080/00914037.2018.1455680. DOI

Siepmann J., Siegel R.A., Rathbone M.J. Fundamentals and Applications of Controlled Release Drug Delivery. Springer; New York, NY, USA: 2011. p. 594.

Thakur V.K., Thakur M.K. Handbook of Polymers for Pharmaceutical Technologies, Biodegradable Polymers. Wiley; Hoboken, NJ, USA: 2015. p. 608.

Koller M., Marsalek L., de Sousa Dias M.M., Braunegg G. Producing microbial polyhydroxyalkanoate (PHA) biopolyesters in a sustainable manner. Pt ANew Biotechnol. 2017;37:24–38. doi: 10.1016/j.nbt.2016.05.001. PubMed DOI

Anjum A., Zuber M., Zia K.M., Noreen A., Anjum M.N., Tabasum S. Microbial production of polyhydroxyalkanoates (PHAs) and its copolymers: A review of recent advancements. Int. J. Biol. Macromol. 2016;89:161–174. doi: 10.1016/j.ijbiomac.2016.04.069. PubMed DOI

Ray S., Kalia V.C. Biomedical Applications of Polyhydroxyalkanoates. Indian J. Microbiol. 2017;57:261–269. doi: 10.1007/s12088-017-0651-7. PubMed DOI PMC

Kovalcik A., Meixner K., Mihalic M., Zeilinger W., Fritz I., Fuchs W., Kucharczyk P., Stelzer F., Drosg B. Characterization of polyhydroxyalkanoates produced by Synechocystis salina from digestate supernatant. Int. J. Biol. Macromol. 2017;102:497–504. doi: 10.1016/j.ijbiomac.2017.04.054. PubMed DOI

Pouton C.W., Akhtar S. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv. Drug Deliv. Rev. 1996;18:133–162. doi: 10.1016/0169-409X(95)00092-L. DOI

Atkins T.W., Peacock S.J. In vitro biodegradation of polyhydroxybutyrate-hydroxyvalerate microcapsules exposed to Hank’s buffer, newborn calf serum, pancreatin and synthetic gastric juice. J. Microencapsul. 1997;14:35–49. doi: 10.3109/02652049709056466. PubMed DOI

Yu J., Plackett D., Chen L.X.L. Kinetics and mechanism of the monomeric products from abiotic hydrolysis of poly[(R)-3-hydroxybutyrate] under acidic and alkaline conditions. Polym. Degrad. Stabil. 2005;89:289–299. doi: 10.1016/j.polymdegradstab.2004.12.026. DOI

Gogolewski S., Jovanovic M., Perren S.M., Dillon J.G., Hughes M.K. Tissue response and in vivo degradation of selected polyhydroxyacids: Polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA) J. Biomed. Mater. Res. 1993;27:1135–1148. doi: 10.1002/jbm.820270904. PubMed DOI

Asiri A.M., Mohammad A. Applications of Nanocomposite Materials in Drug Delivery. Elsevier Science; Cambridge, UK: 2018.

Cao K., Liu Y., Olkhov A., Siracusa V., Iordanskii A. PLLA-PHB fiber membranes obtained by solvent-free electrospinning for short-time drug delivery. Drug Deliv. Transl. Res. 2018;8:291–302. doi: 10.1007/s13346-017-0463-7. PubMed DOI

Acevedo F., Villegas P., Urtuvia V., Seeger M., Hermosilla J., Navia R. Bacterial polyhydroxybutyrate for electrospun fiber production. Int. J. Biol. Macromol. 2018;106:692–697. doi: 10.1016/j.ijbiomac.2017.08.066. PubMed DOI

Ding Y., Li W., Zhang F., Liu Z., Zanjanizadeh Ezazi N., Liu D., Santos H.A. Electrospun Fibrous Architectures for Drug Delivery, Tissue Engineering and Cancer Therapy. Adv. Funct. Mater. 2019:29. doi: 10.1002/adfm.201802852. DOI

Koller M., Koller M. Biodegradable and Biocompatible Polyhydroxy-alkanoates (PHA): Auspicious Microbial Macromolecules for Pharmaceutical and Therapeutic Applications. Molecules. 2018;23:362. doi: 10.3390/molecules23020362. PubMed DOI PMC

Fernandes J.G., Correia D.M., Botelho G., Padrao J., Dourado F., Ribeiro C., Lanceros-Mendez S., Sencadas V. PHB-PEO electrospun fiber membranes containing chlorhexidine for drug delivery applications. Polym. Test. 2014;34:64–71. doi: 10.1016/j.polymertesting.2013.12.007. DOI

Wang C., Yan K.-W., Lin Y.-D., Hsieh P.C.H. Biodegradable Core/Shell Fibers by Coaxial Electrospinning: Processing, Fiber Characterization, and Its Application in Sustained Drug Release. Macromolecules. 2010;43:6389–6397. doi: 10.1021/ma100423x. DOI

Doi Y., Kanesawa Y., Kunioka M., Saito T. Biodegradation of microbial copolyesters: Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) Macromolecules. 1990;23:26–31. doi: 10.1021/ma00203a006. DOI

Lee Y.-F., Sridewi N., Ramanathan S., Sudesh K. The influence of electrospinning parameters and drug loading on polyhydroxyalkanoate (PHA) nanofibers for drug delivery. Int. J. Biotechnol. Wellness Ind. 2015;4:103–113.

Mahaling B., Katti D.S. Fabrication of micro-structures of poly [(R)-3-hydroxybutyric acid] by electro-spraying/-spinning: Understanding the influence of polymer concentration and solvent type. J. Mater. Sci. 2014;49:4246–4260. doi: 10.1007/s10853-014-8120-8. DOI

Mhlanga N., Ray S.S. Kinetic models for the release of the anticancer drug doxorubicin from biodegradable polylactide/metal oxide-based hybrids. Int. J. Biol. Macromol. 2015;72:1301–1307. doi: 10.1016/j.ijbiomac.2014.10.038. PubMed DOI

Naveen N., Kumar R., Balaji S., Uma T.S., Natrajan T.S., Sehgal P.K. Synthesis of Nonwoven Nanofibers by Electrospinning—A Promising Biomaterial for Tissue Engineering and Drug Delivery. Adv. Eng. Mater. 2010;12:B380–B387. doi: 10.1002/adem.200980067. DOI

Levofloxacin. [(accessed on 29 April 2019)]; Available online: https://www.drugbank.ca/drugs/DB01137.

Correia D.M., Ribeiro C., Ferreira J.C., Botelho G., Ribelles J.L.G., Lanceros-Méndez S., Sencadas V. Influence of electrospinning parameters on poly (hydroxybutyrate) electrospun membranes fiber size and distribution. Polym. Eng. Sci. 2014;54:1608–1617. doi: 10.1002/pen.23704. DOI

Sofokleous P., Stride E., Edirisinghe M. Preparation, characterization, and release of amoxicillin from electrospun fibrous wound dressing patches. Pharm. Res. 2013;30:1926–1938. doi: 10.1007/s11095-013-1035-2. PubMed DOI

Fan X., Jiang Q., Sun Z., Li G., Ren X., Liang J., Huang T. Preparation and characterization of electrospun antimicrobial fibrous membranes based on polyhydroxybutyrate (PHB) Fibers Polym. 2015;16:1751–1758. doi: 10.1007/s12221-015-5108-1. DOI

Soares G.M.S., Figueiredo L.C., Faveri M., Cortelli S.C., Duarte P.M., Feres M. Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs. J. Appl. Oral. Sci. 2012;20:295–309. doi: 10.1590/S1678-77572012000300002. PubMed DOI PMC

Kapoor G., Saigal S., Elongavan A. Action and resistance mechanisms of antibiotics: A guide for clinicians. J. Anaesthesiol. Clin. Pharmacol. 2017;33:300–305. doi: 10.4103/joacp.JOACP_349_15. PubMed DOI PMC

Percival S.L., Suleman L., Vuotto C., Donelli G. Healthcare-associated infections, medical devices and biofilms: Risk, tolerance and control. J. Med. Microbiol. 2015;64:323–334. doi: 10.1099/jmm.0.000032. PubMed DOI

Chen S., Liu B., Carlson M.A., Gombart A.F., Reilly D.A., Xie J. Recent advances in electrospun nanofibers for wound healing. Nanomedicine. 2017;12:1335–1352. doi: 10.2217/nnm-2017-0017. PubMed DOI PMC

Enzymatic Hydrolysis of Poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate) Scaffolds

Facile Preparation of Porous Microfiber from Poly-3-(R)-Hydroxybutyrate and Its Application